Unknown Heart, Stroke & Blood NIHR-supported project Diabetes, Hormones & Metabolism
Sclerostin inhibition, cardiovascular biomarkers, and cardiovascular risk: a GWAS meta-analysis, Mendelian Randomisation, and UK Biobank cohort analysis
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by NIHR.
Researchers
Daniel Prieto-Alhambra (Principal Investigator)
Related Research
Grants with similar aims, by meaning.
Pharmacogenomic, genetic and trial-based studies of lipid-modifying therapies and vascular risk
Public health applications of cardiovascular genomics
Understanding the genetic regulation of adrenal steroid hormones in cardiovascular disease - developing a stratified approach to cardiovascular care
The Edinburgh Heart Disease Prevention Study: Common candidate genotypes and conventional risk factors as predictors of 20-year risk of atherosclerotic vascular disease in Scottish men.
Investigation of the role of Bcar1/p130Cas in atherosclerosis
Original classification
MusculoskeletalPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know